Central nervous system involvement in indolent lymphomas

Annals of Oncology

Volumn 16, Issue 3, 2005, Pages 450-454

  Spectre, Galia ^a   Gural, A ^a   Amir, G ^a   Lossos, A ^a   Siegal, T ^a   Paltiel, O ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Central nervous system; Clinical course; Indolent; Non Hodgkin's lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; METHOTREXATE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; B CELL LYMPHOMA; BONE MARROW DISEASE; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; LEPTOMENINX; LYMPHOCYTOMA; MALE; NEUROLOGIC DISEASE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SYMPTOMATOLOGY;

ADULT; AGE OF ONSET; AGED; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 16244389347     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdi076     Document Type: Article

References (27)

1. Tomita N, Kodama F, Sakai R et al. Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations. Leuk Lymphoma 2000; 38: 335-343.
2. Wolf MM, Olver IN, Ding JC et al. Non-Hodgkin's lymphoma involving the central nervous system. Aust N Z Med 1985; 15: 16-21.
3. Mackintosh FR, Colby TV, Podolski WJ et al. Central nervous system involvement in Hodgkin lymphoma: an analysis of 105 cases. Cancer 1982; 49: 586-595.
4. Hollender A, Kvaloy S, Nome O et al. Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model. Ann Oncol 2002; 13: 1099-1107.
5. Liang R, Chiu E, Loke SL. Secondary central nervous system involvement by non-Hodgkin's lymphoma: the risk factors. Hematol Oncol 1990; 8: 141-145.
6. Keldsen N, Michalski S, Bentzen S et al. Risk factors for central nervous involvement in non-Hodgkin's lymphoma. Acta Oncol 1996; 35: 703-708.
7. Van Besien K, Ha CS, Murphy S et al. Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate grade and immunoblastic lymphoma. Blood 1998; 91: 1178-1184.
8. Zinzani PL, Magagnoli M, Ferezza G et al. Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience. Leuk Lymphoma 1999; 32: 571-576.
9. Litam JP, Cabanillas F, Smith TL et al. Central nervous system relapse in malignant lymphomas: risk factors and implications for prophylaxis. Blood 1979; 54: 1249-1257.
10. Young RC, Howser DM, Anderson T et al. Central nervous system complications of non-Hodgkin's lymphoma. The potential role of prophylactic therapy. Am J Med 1979; 66: 435-443.
11. Bollen EL, Brouwer RE, Hamers S et al. Central nervous system relapse in non Hodgkin lymphoma. A single center study of 532 patients. Arch Neurol 1997; 54: 854-859.
12. Oinonen R, Franssila K, Elonen E. Central nervous system involvement in patients with mantle cell lymphoma. Ann Hematol 1999; 78: 145-149.
13. Montserrat E, Bosch F, Lopez-Guillermo A et al. CNS involvement in mantle cell lymphoma. J Clin Oncol 1996; 14: 941-944.
14. Valdez R, Kroft SH, Ross CW et al. Cerebrospinal fluid involvement in mantle cell lymphoma. Mod Pathol 2002; 15: 1073-1079.
15. Hoffman MA, Valderrama E, Fuchs A et al. Leukemic meningitis in B cell prolymphocytic leukemia. A clinical, pathologic and ultrastructural case study and review of the literature. Cancer 1995; 75: 1100-1103.
16. Miller K, Budke H, Orazi A. Leukemic meningitis complicating early stage chronic lymphocytic leukemia. Arch Pathol Lab Med 1997; 121: 524-527.
17. Brick WG, Majmundar M, Hendricks LK et al. Leukemic leptomeningeal involvement in stage 0 and stage 1 chronc lymphocytic leukemia. Leuk Lymphoma 2002; 43: 199-201.
18. Cramer SC, Glapsy JA, Efird JT et al. Chrnic lymphocytic leukemia and the central nervous system: a clinical and pathological study. Neurology 1996; 46: 19-25.
19. Barcos M, Lane W, Gomez GA et al. An autopsy study of 1206 acute and chronic leukemias (1958 to 1982). Cancer 1987; 60: 827-837.
20. Reske-Nielsen, Petersen JH, Sogaard J et al. Leukemia of the central nervous system. Lancet 1994; 211-212.
21. Beriwal S, Hou JS, Miyamoto C, Gracia-Young JA. Primary dural low grade BCL2 negative follicular lymphoma: a case report. J Neurooncol 2003; 61: 23-25.
22. Altundag MK, Ozsik Y, Yalcin S et al. Primary low grade B cell lymphoma of the dura in an immunocompetent patient. J Exp Clin Cancer Res 2000; 19: 249-251.
23. Subramanian S, Bahceci E, Kanji A. Primary follicular lymphoma of the meninges: a case report. Proc Am Soc Clin Oncol 1995; 14: (Abstr 308).
24. Goetz P, Lafuente J, Revesz T et al. Primary low grade B-cell lymphoma of mucosa associated lymphoid tissue of the dura mimicking the presentation of an acute subdural hematoma. Case report and review of the literature. J Neurosurg 2002; 96: 611-614.
25. Scully MA, Dearden CE, Matutes E et al. Central nervous system relapse in chronic B-cell lymphoproliferative disease. Blood Suppl 2003; 102: 287b (Abstr 4872).
26. Child JA, Jack AS, Morgan GJ. The Lymphoproliferative Disorders. London: Chapman and Hall Medical 1998.
27. Recht L, Straus DJ, Cirrincoine C et al. Central nervous system metastasis from non-Hodgkin's lymphoma: Treatment and prophylaxis. Am J Med 1998; 84: 425-435.